查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762541

冷凍乾燥服務市場：產業趨勢及全球預測 - 依冷凍乾燥生物製劑類型、依初級包裝系統類型、依主要地區

Lyophilization Services Market : Industry Trends and Global Forecasts - Distribution by Type of Biologic Lyophilized, Type of Primary Packaging System and Key Geographies
出版日期: | 出版商: Roots Analysis | 英文 225 Pages | 商品交期: 最快1-2個工作天內

價格

冷凍乾燥服務市場：概覽

預計2035年，全球冷凍乾燥服務市場規模將從目前的26億美元成長至49億美元，預測期內年複合成長率為6.3%。

市場區隔包括以下參數的市場規模與機會分析：

冷凍乾燥生物製品類型

  • 抗體
  • 細胞與基因治療藥物
  • 疫苗
  • 其他生物製品

初級包裝系統類型

  • 小瓶
  • 注射器
  • 卡式瓶
  • 安瓿瓶
  • 其他

主要地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和北非

冷凍乾燥服務市場：成長與趨勢

冷凍乾燥是一種藥物穩定技術，可透過冷凍乾燥去除多餘的溶劑（例如水），同時保留藥物的化學性質。冷凍乾燥技術通常使用實驗室冷凍乾燥機、非無菌冷凍乾燥機和可滅菌冷凍乾燥機等專用設備進行冷凍乾燥。值得注意的是，多年來，冷凍乾燥已成為實現更長、更符合商業可行性的保存期限以及穩定乾燥生物製劑的首選方法。然而，生物相似藥和新型生物製劑的快速成長，以及生物製劑冷凍乾燥製程的挑戰，使得利害關係人更加依賴在該領域提供多學科專業知識的服務提供者。

冷凍乾燥服務市場-IMG1

此外，一些市場領導者加速探索冷凍乾燥技術的進步和創新，以提高營運效率並實現乾燥過程中的製程控制。使整個製程更加高效。例如，連續冷凍乾燥系統和自動化冷凍乾燥系統等現代技術鼓勵行業領導者採用這些技術，並滿足客戶客製化的冷凍乾燥服務需求。

冷凍乾燥服務市場：關鍵洞察

本報告分析了冷凍乾燥服務市場的現狀，並探討了潛在的成長機會。主要調查結果包括：

  • 目前，超過 105 家服務提供者聲稱擁有為各種生物療法藥物（包括蛋白質、抗體、核酸和細胞/基因療法）提供冷凍乾燥服務的必要專業知識。
  • 目前的市場格局高度分散，新進業者和現有企業都位於關鍵地區。
  • 利害關係人利用其專業知識提供各種規模的冷凍乾燥服務。此外，小瓶已成為儲存生物製劑的首選初級包裝系統。
冷凍乾燥服務市場-IMG2
  • 為了因應不斷變化的監管環境，服務提供者擴展其產品組合，以滿足客戶的客製化需求。
  • 合作活動的增加表明了人們對該領域日益成長的興趣；事實上，與生物製劑冷凍乾燥相關的合作數量已達到兩年來的最高水準。
  • 為了滿足日益成長的需求，許多公司採取擴張措施，以增強其服務組合，包括建立新設施和擴大現有產能。
  • 預計到2035年，該市場將保持穩定成長，預計機會將均勻分佈在各種類型的生物製劑冷凍乾燥、初級包裝系統和地理區域。
冷凍乾燥服務市場-IMG3

冷凍乾燥服務市場：主要細分市場

根據冷凍乾燥的生物製品類型，市場細分為抗體、細胞和基因治療、疫苗以及其他生物製品。目前，抗體領域在全球冷凍乾燥服務市場中佔有最大佔有率。由於用於治療多種疾病的標靶藥物需求不斷成長，這一趨勢在未來幾年可能保持不變。

根據初級包裝系統的類型，市場細分為小瓶、注射器、卡式瓶、安瓿瓶和其他類型。目前，小瓶領域在全球冷凍乾燥服務市場中佔有最大佔有率。然而，由於對自動給藥注射劑和預充式註射器的需求不斷成長，預計注射器市場在預測期內將以更高的年複合成長率成長。

依主要地區劃分，市場分為北美、歐洲、亞太地區、拉丁美洲、中東和北非、拉丁美洲。目前，北美在全球冷凍乾燥服務市場佔據主導地位，佔據最大的收入佔有率。此外，未來幾年亞太地區市場可能會以更高的年複合成長率成長。

進入冷凍乾燥服務市場的公司範例

  • Baxter BioPharma Solutions
  • CordenPharma
  • Coriolis Pharma
  • Curia
  • Emergent BioSolutions
  • LSNE Contract Manufacturing
  • Lyophilization Technology
  • Northway Biotech
  • ProJect Pharmaceutics
  • Vetter Pharma

目錄

第1章 前言

第2章 執行摘要

第3章 引言

  • 章節概述
  • 冷凍乾燥概述
  • 生物製劑冷凍乾燥
  • 冷凍乾燥設備及其關鍵技術組件
  • 用於生物製劑冷凍乾燥的初級包裝系統
  • 冷凍乾燥週期的開發與最佳化
  • 結論

第4章 市場格局

  • 章節概述
  • 生物製劑冷凍乾燥服務提供者：市場格局

第5章 基準分析

  • 章節概述
  • 研究方法
  • 基準分析：同業組

第6章 公司簡介：北美生物製劑冷凍乾燥服務提供者

  • 章節概述
  • Baxter BioPharma Solutions
  • Curia
  • Emergent BioSolutions
  • LSNE Contract Manufacturing
  • Lyophilization Technology

第7章 公司簡介：歐洲生物製劑冷凍乾燥服務提供者

  • 章節概述
  • CordenPharma
  • Coriolis Pharma
  • Northway Biotech
  • ProJect Pharmaceutics
  • Vetter Pharma

第8章 公司簡介：亞太地區生物製劑冷凍乾燥服務提供者

  • 章節概述
  • BioZed Engineering
  • CinnaGen
  • MabPlex
  • Samsung Biologics
  • WuXi Biologics

第9章 合作夥伴與合作

  • 章節概述
  • 合作夥伴模式
  • 生物製品冷凍乾燥服務：合作夥伴與合作列表

第10章 近期拓展

  • 章節概述
  • 生物製品冷凍乾燥服務：近期拓展列表

第11章 研究與分析

  • 章節概述
  • 生物製品冷凍乾燥服務：參與者列表

第12章 案例研究 I：冷凍乾燥週期開發與最佳化

  • 章節概述
  • 冷凍乾燥週期發展
  • 冷凍乾燥週期最佳化
  • 冷凍乾燥週期開發與最佳化：服務提供者列表

第13章 案例研究2：冷凍乾燥的替代方法

  • 章節概述
  • 冷凍乾燥的替代方法

第14章 市場預測與機會分析

  • 章節概述
  • 預測研究方法與關鍵假設
  • 全球生物製品冷凍乾燥服務市場（～2035年）
  • 生物製品冷凍乾燥服務市場：依冷凍乾燥生物製品類型
  • 生物製品冷凍乾燥服務市場：依初級包裝系統類型
  • 生物製品冷凍乾燥服務市場區域：依初級包裝系統類型

第15章 結論

第16章 高層洞察

附錄1：表格資料

附錄2：公司與組織清單

Product Code: RA100345

LYOPHILIZATION SERVICES MARKET: OVERVIEW

As per Roots Analysis, the global lyophilization services market is estimated to grow from USD 2.6 billion in the current year to USD 4.9 billion by 2035, at a CAGR of 6.3% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biologic Lyophilized

  • Antibodies
  • Cells and Gene Therapies
  • Vaccines
  • Other Biologics

Type of Primary Packaging System

  • Vials
  • Syringes
  • Cartridges
  • Ampoules
  • Others

Key Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and North Africa

LYOPHILIZATION SERVICES MARKET: GROWTH AND TRENDS

Lyophilization is a drug stabilization technique that involves removing excess solvents, such as water, through freeze-drying while preserving the chemical properties of the substance. Notably, lyophilization utilizes specialized equipment, including laboratory freeze dryers, non-sterile freeze dryers, and sterilizable lyophilizers. It is worth highlighting that over the years, lyophilization has emerged as the preferred approach to achieve longer and commercially viable shelf lives, enabling stable and dry biopharmaceutical formulations. However, characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers that offer multidisciplinary expertise in this domain.

Lyophilization Services Market - IMG1

In addition, several market leaders are accelerating their research for lyophilization technology advancements and innovations to improve working efficiency and achieve process control during the drying process. This has resulted in improved productivity and efficiency of the overall process. For instance, latest technologies, such as continuous freeze-drying systems and automated lyophilization systems, are encouraging industrial leaders to adopt these technologies and meet the customized lyophilization services requirements of clients.

LYOPHILIZATION SERVICES MARKET: KEY INSIGHTS

The report delves into the current state of the lyophilization services market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Presently, over 105 service providers claim to have the required expertise to offer lyophilization services for a variety of biotherapeutics, including proteins, antibodies, nucleic acids and cell / gene therapies.
  • The current market landscape is highly fragmented, featuring the presence of both new entrants and established players based in key geographical regions.
  • Leveraging their expertise, stakeholders are offering lyophilization services at different scales of operation; further, vials emerged as the preferred choice of primary packaging system for storing biologics.
Lyophilization Services Market - IMG2
  • In order to successfully navigate the evolving regulatory landscape, service providers are expanding their portfolios to cater to customized requests of their clients.
  • The growing interest in this domain is evident from the rise in partnership activity; in fact, the maximum number of collaborations related to lyophilization of biopharmaceuticals were signed in the past two years.
  • To keep pace with the growing demand, many companies have undertaken expansion initiatives, such as establishing new facilities or expanding their existing capabilities, to strengthen their service portfolio.
  • The market is expected to grow at a steady rate till 2035; the projected opportunity is anticipated to be well distributed across various types of biologic lyophilized, primary packaging systems and geographical regions.
Lyophilization Services Market - IMG3

LYOPHILIZATION SERVICES MARKET: KEY SEGMENTS

Antibodies Segment holds the Largest Share of the Lyophilization Services Market

Based on the type of biologics lyophilized, the market is segmented into antibodies, cell and gene therapies, vaccines, and other biologics. At present, the antibodies segment holds the maximum share of the global lyophilization services market. This trend is likely to remain the same in the coming years owing to the increasing demand for target-specific drugs for the treatment of a myriad of diseases.

By Type of Primary Packaging System, Syringes is the Fastest Growing Segment of the Global Lyophilization Services Market

Based on the type of primary packaging system, the market is segmented into vials, syringes, cartridges, ampoules, and others. At present, the vials segment holds the maximum share of the global lyophilization services market. However, the market for syringes segment is expected to grow at a higher CAGR during the forecast period owing to the growing demand for automated drug delivery injections and prefilled syringes.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Latin America. Currently, North America dominates the global lyophilization services market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Lyophilization Services Market

  • Baxter BioPharma Solutions
  • CordenPharma
  • Coriolis Pharma
  • Curia
  • Emergent BioSolutions
  • LSNE Contract Manufacturing
  • Lyophilization Technology
  • Northway Biotech
  • ProJect Pharmaceutics
  • Vetter Pharma

LYOPHILIZATION SERVICES MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global lyophilization services market, focusing on key market segments, including [A] type of biologic lyophilized, [B] type of primary packaging system and [C] key geographies.
  • Market Landscape: A comprehensive evaluation of the companies offering lyophilization services, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] the scale of operation, [E] regulatory certification / accreditation, [F] type of biologic lyophilized, [G] the process of lyophilization, [H] type of primary packaging system and [I] additional services offered by the firms.
  • Benchmark Analysis: A comprehensive benchmark analysis of various service providers segregated into three peer groups based on the location of their headquarters. Additionally, the companies were further distributed across key geographies, based on their employee count, into three categories, namely [A] small, [B] mid-sized and [C] large / very large, highlighting the top players in the lyophilization services market, based on their respective capabilities.
  • Company Profiles: In-depth profiles of key players that are currently engaged in offering lyophilization services for biopharmaceuticals, focusing on [A] overview of the company, [B] lyophilization service offerings for biopharmaceuticals, [C] dedicated facilities and [D] recent developments and an informed future outlook.
  • Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in this domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] most active players (in terms of the number of partnerships signed) and [D] geographical distribution.
  • Recent Expansions: In-depth analysis of the various expansion initiatives undertaken by lyophilization service providers for biopharmaceuticals, based on several parameters, such as [A] year of expansion, [B] type of expansion, [C] company size, [D] location of headquarters, [E] location of expanded facility, [F] most active players (in terms of number of recent expansions) and [G] geographical distribution.
  • Survey Analysis: An insightful analysis presenting additional insights on lyophilization services offered for biopharmaceuticals, based on several parameters, such as [A] type of biologic lyophilized, [B] type of primary packaging system, [C] scale of operation, [D] availability of lyophilization cycle development / optimization capabilities and [E] location of a dedicated manufacturing facility for lyophilization.
  • Case Study 1: A detailed discussion on lyophilization cycle development and optimization services, highlighting the important parameters and techniques required for these processes.
  • Case Study 2: A comprehensive discussion on the alternative approaches to the lyophilization process, such as [A] spray drying, [B] spray freeze dryer, [C] atmospheric spray freeze dryer, and [D] vacuum foam drying.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Overview of Lyophilization
    • 3.2.1. Historical Evolution
    • 3.2.2. Underlying Principles
    • 3.2.3. Advantages and Disadvantages
  • 3.3. Lyophilization of Biopharmaceuticals
    • 3.3.1. Need for Lyophilization of Biopharmaceuticals
    • 3.3.2. Lyophilization Process
      • 3.3.2.1. Formulation and Filling
      • 3.3.2.2. Freezing
      • 3.3.2.3. Primary Drying
      • 3.3.2.4. Secondary Drying
  • 3.4. Lyophilizer and its Key Components
  • 3.5. Primary Packaging Systems Used for Lyophilization of Biopharmaceuticals
  • 3.6. Lyophilization Cycle Development and Optimization
  • 3.7. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Scale of Operation
    • 4.2.5. Analysis by Regulatory Certification / Accreditation
    • 4.2.6. Analysis by Type of Biologic Lyophilized
    • 4.2.7. Analysis by Process of Lyophilization
    • 4.2.8. Analysis by Type of Primary Packaging System
    • 4.2.9. Analysis by Additional Services Offered

5. BENCHMARK ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Methodology
  • 5.3. Benchmark Analysis: Peer Groups
    • 5.3.1. Benchmark Analysis: North America (Peer Group I)
    • 5.3.2. Benchmark Analysis: North America (Peer Group II)
    • 5.3.3. Benchmark Analysis: North America (Peer Group III)
    • 5.3.4. Benchmark Analysis: Europe (Peer Group IV)
    • 5.3.5. Benchmark Analysis: Europe (Peer Group V)
    • 5.3.6. Benchmark Analysis: Europe (Peer Group VI)
    • 5.3.7. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
    • 5.3.8. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)

6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA

  • 6.1. Chapter Overview
  • 6.2. Baxter BioPharma Solutions
    • 6.2.1. Company Overview
    • 6.2.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 6.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 6.2.4. Recent Developments and Future Outlook
  • 6.3. Curia
    • 6.3.1. Company Overview
    • 6.3.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 6.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 6.3.4. Recent Developments and Future Outlook
  • 6.4. Emergent BioSolutions
    • 6.4.1. Company Overview
    • 6.4.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 6.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 6.4.4. Recent Developments and Future Outlook
  • 6.5. LSNE Contract Manufacturing
    • 6.5.1. Company Overview
    • 6.5.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 6.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 6.5.4. Recent Developments and Future Outlook
  • 6.6. Lyophilization Technology
    • 6.6.1. Company Overview
    • 6.6.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 6.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 6.6.4. Recent Developments and Future Outlook

7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE

  • 7.1. Chapter Overview
  • 7.2. CordenPharma
    • 7.2.1. Company Overview
    • 7.2.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 7.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Coriolis Pharma
    • 7.3.1. Company Overview
    • 7.3.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 7.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. Northway Biotech
    • 7.4.1. Company Overview
    • 7.4.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 7.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. ProJect Pharmaceutics
    • 7.5.1. Company Overview
    • 7.5.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 7.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 7.5.4. Recent Developments and Future Outlook
  • 7.6. Vetter Pharma
    • 7.6.1. Company Overview
    • 7.6.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 7.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 7.6.4. Recent Developments and Future Outlook

8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC

  • 8.1. Chapter Overview
  • 8.2. BioZed Engineering
    • 8.2.1. Company Overview
    • 8.2.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 8.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 8.2.4. Recent Developments and Future Outlook
  • 8.3. CinnaGen
    • 8.3.1. Company Overview
    • 8.3.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 8.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 8.3.4. Recent Developments and Future Outlook
  • 8.4. MabPlex
    • 8.4.1. Company Overview
    • 8.4.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 8.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 8.4.4. Recent Developments and Future Outlook
  • 8.5. Samsung Biologics
    • 8.5.1. Company Overview
    • 8.5.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 8.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 8.5.4. Recent Developments and Future Outlook
  • 8.6. WuXi Biologics
    • 8.6.1. Company Overview
    • 8.6.2. Lyophilization Service Offerings for Biopharmaceuticals
    • 8.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
    • 8.6.4. Recent Developments and Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

  • 9.1. Chapter Overview
  • 9.2. Partnership Models
  • 9.3. Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations
    • 9.3.1. Analysis by Year of Partnership
    • 9.3.2. Analysis by Type of Partnership
    • 9.3.3. Analysis by Year and Type of Partnership
    • 9.3.4. Most Active Players: Analysis by Number of Partnerships
    • 9.3.5. Analysis by Geography
      • 9.3.5.1. Intercontinental and Intracontinental Deals
      • 9.3.5.2. International and Local Deals

10. RECENT EXPANSIONS

  • 10.1. Chapter Overview
  • 10.2. Lyophilization Services Market for Biopharmaceuticals: List of Recent Expansions
    • 10.2.1. Analysis by Year of Expansion
    • 10.2.2. Analysis by Type of Expansion
    • 10.2.3. Analysis by Year and Type of Expansion
    • 10.2.4. Analysis by Company Size and Location of Headquarters
    • 10.2.5. Analysis by Location of Expanded Facility
    • 10.2.6. Active Players: Analysis by Number of Recent Expansions
    • 10.2.7. Analysis by Geography

11. SURVEY ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Lyophilization Services Market for Biopharmaceuticals: List of Participating Companies
    • 11.2.1. Analysis by Seniority Level of Respondents
    • 11.2.2. Analysis by Type of Biologic Lyophilized
    • 11.2.3. Analysis by Type of Primary Packaging System
    • 11.2.4. Analysis by Scale of Operation
    • 11.2.5. Analysis by Additional Services Offered
    • 11.2.6. Analysis by Location of Lyophilization Facility
    • 11.2.7. Analysis by Share of Lyophilization Operations Outsourced
    • 11.2.8. Analysis by Likely Market Size
    • 11.2.9. Analysis of Likely Market Share by Type of Biologic Lyophilized
    • 11.2.10. Analysis of Likely Market Share by Geography

12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION

  • 12.1. Chapter Overview
  • 12.2. Lyophilization Cycle Development
  • 12.3. Lyophilization Cycle Optimization
  • 12.4. Lyophilization Cycle Development and Optimization: List of Service Providers
    • 12.4.1. Analysis by Company Size
    • 12.4.2. Analysis by Location of Headquarters
    • 12.4.3. Analysis by Type of Service Offered
    • 12.4.4. Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots

13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION

  • 13.1. Chapter Overview
  • 13.2. Alternative Approaches to Lyophilization
    • 13.2.1. Spray Drying
      • 13.2.1.1. Spray Drying Process
      • 13.2.1.2. Applications of Spray Drying
      • 13.2.1.3. Spray Drying of Biopharmaceuticals
      • 13.2.1.4. Spray Drying Service Providers for Biopharmaceuticals
      • 13.2.1.5. Comparison of Lyophilization and Spray Drying
    • 13.2.2. Spray Freeze Drying
    • 13.2.3. Atmospheric Spray Freeze Drying
    • 13.2.4. Vacuum Foam Drying

14. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 14.1. Chapter Overview
  • 14.2. Forecast Methodology and Key Assumptions
  • 14.3. Global Lyophilization Services Market for Biopharmaceuticals, Till 2035
  • 14.4. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
    • 14.4.1. Lyophilization Services Market for Antibodies, Till 2035
    • 14.4.2. Lyophilization Services Market for Cell and Gene Therapies, Till 2035
    • 14.4.3. Lyophilization Services Market for Vaccines, Till 2035
    • 14.4.4. Lyophilization Services Market for Other Biologics, Till 2035
  • 14.5. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System
    • 14.5.1. Lyophilization Services Market for Biopharmaceuticals for Vials, Till 2035
    • 14.5.2. Lyophilization Services Market for Biopharmaceuticals for Syringes, Till 2035
    • 14.5.3. Lyophilization Services Market for Biopharmaceuticals for Cartridges, Till 2035
    • 14.5.4. Lyophilization Services Market for Biopharmaceuticals for Ampoules, Till 2035
    • 14.5.5. Lyophilization Services Market for Biopharmaceuticals for Other Primary Packaging Systems, Till 2035
  • 14.6. Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography
    • 14.6.1. Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035
    • 14.6.2. Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035
    • 14.6.3. Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035
    • 14.6.4. Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035
    • 14.6.5. Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035
    • 14.6.6. Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

  • 16.1. Chapter Overview
  • 16.2. Company A
    • 16.2.1. Company Snapshot
    • 16.2.2. Interview Transcript
  • 16.3. Company B
    • 16.3.1. Company Snapshot
    • 16.3.2. Interview Transcript
  • 16.4. Company C
    • 16.4.1. Company Snapshot
    • 16.4.2. Interview Transcript
  • 16.5. Company D
    • 16.5.1. Company Snapshot
    • 16.5.2. Interview Transcript
  • 16.6. Company E
    • 16.6.1. Company Snapshot
    • 16.6.2. Interview Transcript
  • 16.7. Company F
    • 16.7.1. Company Snapshot
    • 16.7.2. Interview Transcript
  • 16.8. Company G
    • 16.8.1. Company Snapshot
    • 16.8.2. Interview Transcript
  • 16.9. Company H
    • 16.9.1. Company Snapshot
    • 16.9.2. Interview Transcript
  • 16.10. Company I
    • 16.10.1. Company Snapshot
    • 16.10.2. Interview Transcript
  • 16.11. Company J
    • 16.11.1. Company Snapshot
    • 16.11.2. Interview Transcript

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 List of Lyophilization Service Providers for Biopharmaceuticals
  • Table 5.1 Benchmark Analysis: Information on Peer Groups
  • Table 6.1 Leading Lyophilization Service Providers for Biopharmaceuticals in North America
  • Table 6.2 Baxter BioPharma Solutions: Company Snapshot
  • Table 6.3 Baxter BioPharma Solutions: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 6.4 Baxter BioPharma Solutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 6.5 Baxter BioPharma Solutions: Recent Developments and Future Outlook
  • Table 6.6 Curia: Company Snapshot
  • Table 6.7 Curia: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 6.8 Curia: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 6.9 Curia: Recent Developments and Future Outlook
  • Table 6.10 Emergent BioSolutions: Company Snapshot
  • Table 6.11 Emergent BioSolutions: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 6.12 Emergent BioSolutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 6.13 Emergent BioSolutions: Recent Developments and Future Outlook
  • Table 6.14 LSNE Contract Manufacturing: Company Snapshot
  • Table 6.15 LSNE Contract Manufacturing: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 6.16 LSNE Contract Manufacturing: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 6.17 LSNE Contract Manufacturing: Recent Developments and Future Outlook
  • Table 6.18 Lyophilization Technology: Company Snapshot
  • Table 6.19 Lyophilization Technology: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 6.20 Lyophilization Technology: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 6.21 Lyophilization Technology: Recent Developments and Future Outlook
  • Table 7.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Europe
  • Table 7.2 CordenPharma: Company Snapshot
  • Table 7.3 CordenPharma: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 7.4 CordenPharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 7.5 CordenPharma: Recent Developments and Future Outlook
  • Table 7.6 Coriolis Pharma: Company Snapshot
  • Table 7.7 Coriolis Pharma: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 7.8 Coriolis Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 7.9 Coriolis Pharma: Recent Developments and Future Outlook
  • Table 7.10 Northway Biotech: Company Snapshot
  • Table 7.11 Northway Biotech: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 7.12 Northway Biotech: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 7.13 Northway Biotech: Recent Developments and Future Outlook
  • Table 7.14 ProJect Pharmaceutics: Company Snapshot
  • Table 7.15 ProJect Pharmaceutics: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 7.16 ProJect Pharmaceutics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 7.17 Vetter Pharma: Company Snapshot
  • Table 7.18 Vetter Pharma: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 7.19 Vetter Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 7.20 Vetter Pharma: Recent Developments and Future Outlook
  • Table 8.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Asia Pacific
  • Table 8.2 BioZed Engineering: Company Snapshot
  • Table 8.3 BioZed Engineering: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 8.4 BioZed Engineering: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 8.5 BioZed Engineering: Recent Developments and Future Outlook
  • Table 8.6 CinnaGen: Company Snapshot
  • Table 8.7 CinnaGen: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 8.8 CinnaGen: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 8.9 CinnaGen: Recent Developments and Future Outlook
  • Table 8.10 MabPlex: Company Snapshot
  • Table 8.11 MabPlex: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 8.12 MabPlex: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 8.13 MabPlex: Recent Developments and Future Outlook
  • Table 8.14 Samsung Biologics: Company Snapshot
  • Table 8.15 Samsung Biologics: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 8.16 Samsung Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 8.17 Samsung Biologics: Recent Developments and Future Outlook
  • Table 8.18 WuXi Biologics: Company Snapshot
  • Table 8.19 WuXi Biologics: Lyophilization Service Offerings for Biopharmaceuticals
  • Table 8.20 WuXi Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
  • Table 8.21 WuXi Biologics: Recent Developments and Future Outlook
  • Table 9.1 Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations, Since 2018
  • Table 10.1 Lyophilization Services for Biopharmaceuticals: List of Recent Expansions, Since 2018
  • Table 11.1 Lyophilization Services Market for Biopharmaceuticals: List of Respondents
  • Table 12.1 Lyophilization Cycle Development and Optimization: List of Service Providers
  • Table 12.2 BSP Pharmaceuticals: Company Snapshot
  • Table 12.3 CuriRx: Company Snapshot
  • Table 12.4 GILYOS: Company Snapshot
  • Table 12.5 Pierre Fabre: Company Snapshot
  • Table 12.6 Singota Solutions: Company Snapshot
  • Table 13.1 Spray Drying for Biopharmaceuticals: List of Service Providers
  • Table 13.2 Comparison of Lyophilization and Spray Drying Process
  • Table 16.1 Pharmaceutical International: Company Snapshot
  • Table 16.2 Curia: Company Snapshot
  • Table 16.3 Emergent BioSolutions: Company Snapshot
  • Table 16.4 Liof Pharma: Company Snapshot
  • Table 16.5 Vibalogics: Company Snapshot
  • Table 16.6 Samsung Biologics: Company Snapshot
  • Table 16.7 Bioserv: Company Snapshot
  • Table 16.8 Symbiosis Pharmaceutical Services: Company Snapshot
  • Table 16.9 Patheon: Company Snapshot
  • Table 16.10 Baxter BioPharma Solutions: Company Snapshot
  • Table 17.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
  • Table 17.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
  • Table 17.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
  • Table 17.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
  • Table 17.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
  • Table 17.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
  • Table 17.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
  • Table 17.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
  • Table 17.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
  • Table 17.10 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VII
  • Table 17.11 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VIII
  • Table 17.12 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2018
  • Table 17.13 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 17.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 17.15 Most Active Players: Distribution by Number of Partnerships
  • Table 17.16 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
  • Table 17.17 Partnerships and Collaborations: International and Local Deals
  • Table 17.18 Recent Expansions: Cumulative Year-wise Trend, Since 2018
  • Table 17.19 Recent Expansions: Distribution by Type of Expansion
  • Table 17.20 Recent Expansions: Distribution by Year and Type of Expansion
  • Table 17.21 Recent Expansions: Distribution by Company Size and Location of Headquarters
  • Table 17.22 Recent Expansions: Distribution by Location of Expanded Facility
  • Table 17.23 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
  • Table 17.24 Active Players: Distribution by Number of Recent Expansions
  • Table 17.25 Recent Expansions: Distribution by Geography
  • Table 17.26 Survey Analysis: Distribution by Geographical Location of Respondents
  • Table 17.27 Survey Analysis: Distribution by Seniority Levels of Respondents
  • Table 17.28 Survey Analysis: Distribution by Type of Biologic Lyophilized
  • Table 17.29 Survey Analysis: Distribution by Type of Primary Packaging System
  • Table 17.30 Survey Analysis: Distribution by Scale of Operation
  • Table 17.31 Survey Analysis: Distribution by Additional Services Offered
  • Table 17.32 Survey Analysis: Distribution by Location of Lyophilization Facility
  • Table 17.33 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
  • Table 17.34 Survey Analysis: Distribution by Likely Current Market Size
  • Table 17.35 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
  • Table 17.36 Survey Analysis: Distribution Likely Market Share by Geography
  • Table 17.37 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
  • Table 17.38 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
  • Table 17.39 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
  • Table 17.40 Global Lyophilization Services Market for Biopharmaceuticals, Till 2035 (USD Billion)
  • Table 17.41 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized (USD Billion)
  • Table 17.42 Lyophilization Services Market for Antibodies, Till 2035 (USD Billion)
  • Table 17.43 Lyophilization Services Market for Cell and Gene Therapies, Till 2035 (USD Billion)
  • Table 17.44 Lyophilization Services Market for Vaccines, Till 2035 (USD Billion)
  • Table 17.45 Lyophilization Services Market for Other Biologics, Till 2035 (USD Billion)
  • Table 17.46 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System (USD Billion)
  • Table 17.47 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, Till 2035 (USD Billion)
  • Table 17.48 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, Till 2035 (USD Billion)
  • Table 17.49 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, Till 2035 (USD Billion)
  • Table 17.50 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, Till 2035 (USD Billion)
  • Table 17.51 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, Till 2035 (USD Billion)
  • Table 17.52 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography (USD Billion)
  • Table 17.53 Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035 (USD Billion)
  • Table 17.54 Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035 (USD Billion)
  • Table 17.55 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035 (USD Billion)
  • Table 17.56 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035 (USD Billion)
  • Table 17.57 Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035 (USD Billion)
  • Table 17.58 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035 (USD Billion)

List of Figures

  • Figure 2.1 Executive Summary: Overall Market Landscape
  • Figure 2.2 Executive Summary: Partnerships and Collaborations
  • Figure 2.3 Executive Summary: Recent Expansions
  • Figure 2.4 Executive Summary: Survey Analysis
  • Figure 2.5 Executive Summary: Market Forecast
  • Figure 3.1 Historical Evolution of Lyophilization
  • Figure 3.2 Phase Diagram of Water
  • Figure 3.3 Sublimation of Ice Crystals
  • Figure 3.4 Key Steps Involved in Formulation and Filling of Biopharmaceuticals
  • Figure 3.5 Key Components of Lyophilizer
  • Figure 4.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
  • Figure 4.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
  • Figure 4.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
  • Figure 4.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
  • Figure 4.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
  • Figure 4.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
  • Figure 4.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
  • Figure 4.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
  • Figure 4.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
  • Figure 5.1 Benchmark Analysis: Distribution by Company Size
  • Figure 5.2 Benchmark Analysis: North America (Peer Group I)
  • Figure 5.3 Benchmark Analysis: North America (Peer Group II)
  • Figure 5.4 Benchmark Analysis: North America (Peer Group III)
  • Figure 5.5 Benchmark Analysis: Europe (Peer Group IV)
  • Figure 5.6 Benchmark Analysis: Europe (Peer Group V)
  • Figure 5.7 Benchmark Analysis: Europe (Peer Group VI)
  • Figure 5.8 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
  • Figure 5.9 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)
  • Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2018
  • Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 9.4 Most Active Players: Distribution by Number of Partnerships
  • Figure 9.5 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
  • Figure 9.6 Partnerships and Collaborations: International and Local Deals
  • Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, Since 2018
  • Figure 10.2 Recent Expansions: Distribution by Type of Expansion
  • Figure 10.3 Recent Expansions: Distribution by Year and Type of Expansion
  • Figure 10.4 Recent Expansions: Distribution by Company Size and Location of Headquarters
  • Figure 10.5 Recent Expansions: Distribution by Location of Expanded Facility
  • Figure 10.6 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
  • Figure 10.7 Active Players: Distribution by Number of Recent Expansions
  • Figure 10.8 Recent Expansions: Distribution by Geography
  • Figure 11.1 Survey Analysis: Distribution by Geographical Location of Respondents
  • Figure 11.2 Survey Analysis: Distribution by Seniority Levels of Respondents
  • Figure 11.3 Survey Analysis: Distribution by Type of Biologic Lyophilized
  • Figure 11.4 Survey Analysis: Distribution by Type of Primary Packaging System
  • Figure 11.5 Survey Analysis: Distribution by Scale of Operation
  • Figure 11.6 Survey Analysis: Distribution by Additional Services Offered
  • Figure 11.7 Survey Analysis: Distribution by Location of Lyophilization Facility
  • Figure 11.8 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
  • Figure 11.9 Survey Analysis: Distribution by Likely Current Market Size
  • Figure 11.10 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
  • Figure 11.11 Survey Analysis: Distribution of Likely Market Share by Geography
  • Figure 12.1 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
  • Figure 12.2 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
  • Figure 12.3 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
  • Figure 13.1 Key Steps Involved in Spray Drying Process
  • Figure 14.1 Global Lyophilization Services Market for Biopharmaceuticals, Till 2035 (USD Billion)
  • Figure 14.2 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, (USD Billion)
  • Figure 14.3 Lyophilization Services Market for Antibodies, Till 2035 (USD Billion)
  • Figure 14.4 Lyophilization Services Market for Cell and Gene Therapies, Till 2035 (USD Billion)
  • Figure 14.5 Lyophilization Services Market for Vaccines, Till 2035 (USD Billion)
  • Figure 14.6 Lyophilization Services Market for Other Biologics, Till 2035 (USD Billion)
  • Figure 14.7 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, (USD Billion)
  • Figure 14.8 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, Till 2035 (USD Billion)
  • Figure 14.9 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, Till 2035 (USD Billion)
  • Figure 14.10 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, Till 2035 (USD Billion)
  • Figure 14.11 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, Till 2035 (USD Billion)
  • Figure 14.12 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, Till 2035 (USD Billion)
  • Figure 14.13 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, (USD Billion)
  • Figure 14.14 Lyophilization Services Market for Biopharmaceuticals in North America, Till 2035 (USD Billion)
  • Figure 14.15 Lyophilization Services Market for Biopharmaceuticals in Europe, Till 2035 (USD Billion)
  • Figure 14.16 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, Till 2035 (USD Billion)
  • Figure 14.17 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, Till 2035 (USD Billion)
  • Figure 14.18 Lyophilization Services Market for Biopharmaceuticals in Latin America, Till 2035 (USD Billion)
  • Figure 14.19 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, Till 2035 (USD Billion)
  • Figure 15.1 Concluding Remarks: Overall Market Landscape
  • Figure 15.2 Concluding Remarks: Benchmark Analysis
  • Figure 15.3 Concluding Remarks: Partnership and Collaborations
  • Figure 15.4 Concluding Remarks: Recent Expansions
  • Figure 15.5 Concluding Remarks: Market Forecast